Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Efficacy of Femoral and Sciatic Nerve Blocks Added to Obturator Nerve Block in Preventing the Obturator Reflex

NCT07922941 is registered in ClinicalTrials.gov with Tuna Erturk as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07922941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Efficacy of Femoral and Sciatic Nerve Blocks Added to Obturator Nerve Block in Preventing the Obturator Reflex
Lead sponsor
Tuna Erturk
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 2, 2026
Completion date
February 2, 2027
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obturator reflex

Arms

As registered; 3 arms.

  • Obturator Nerve Block (ONB) Active comparatorObturator Nerve Block

    Patients will receive an ultrasound-guided obturator nerve block.

  • ONB + FNB ExperimentalFemoral Nerve Block, Obturator Nerve Block

    Patients will receive ultrasound-guided obturator and femoral nerve blocks.

  • ONB + FNB + SNB ExperimentalFemoral Nerve Block, Obturator Nerve Block, Sciatic Nerve Block

    Patients will receive ultrasound-guided obturator, femoral, and sciatic nerve blocks.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Number of Participants With at Least One Intraoperative Adductor Muscle Contraction On the day of surgery, during transurethral tumor resection

    Participants experiencing at least one adductor muscle contraction during transurethral bladder tumor resection will be recorded. The number and proportion of affected participants will be compared across the three groups.